Melissa Merritt to Anti-Inflammatory Agents, Non-Steroidal
This is a "connection" page, showing publications Melissa Merritt has written about Anti-Inflammatory Agents, Non-Steroidal.
Connection Strength
0.988
-
Merritt MA, Rice MS, Barnard ME, Hankinson SE, Matulonis UA, Poole EM, Tworoger SS. Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS/NHSII): a cohort study. Lancet Oncol. 2018 08; 19(8):1107-1116.
Score: 0.519
-
Merritt MA, Green AC, Nagle CM, Webb PM. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer. 2008 Jan 01; 122(1):170-6.
Score: 0.250
-
Hurwitz LM, O'Brien KM, Townsend MK, Reid BM, Fridley BL, Fan W, Schabath MB, Bodelon C, Chan AT, Fortner RT, H?kansson N, Harris HR, Lacey JV, Liao LM, Merritt MA, Patel AV, Poynter JN, Robien K, Sandler DP, Wentzensen N, Wolk A, Zheng W, Tworoger SS, Trabert B. Longer-term aspirin use and subsequent ovarian cancer risk in the Ovarian Cancer Cohort Consortium. Int J Epidemiol. 2026 Feb 18; 55(2).
Score: 0.219